Novo Nordisk Research and Development (R&D) is dedicated to building on our 100-year heritage of putting patients first and collaborating for the future of innovative medicines. We have more than 600 scientists and engineers who develop and manage our R&D program around the world -- exploring novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, hemophilia, growth hormone-related disorders and non-alcoholic steatohepatitis (NASH).